Eyler, Christine E.
Matsunaga, Hironori
Hovestadt, Volker
Vantine, Samantha J.
van Galen, Peter
Bernstein, Bradley E.
Funding for this research was provided by:
Harvard Catalyst
National Cancer Institute (DP1CA216873)
Starr Cancer Consortium (I9-A9-071)
Article History
Received: 27 January 2020
Accepted: 25 June 2020
First Online: 15 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: B.E.B. declares outside interests in Fulcrum Therapeutics, 1CellBio, HiFiBio, Arsenal Biosciences, Cell Signaling Technologies, BioMillenia, and Nohla Therapeutics. H.M. is a paid employee of Daiichi Sankyo Co. The other authors declare that they have no competing interests.